Multidrug-resistant Tuberculosis
📧 Sign up to get email alerts when something new happens for Multidrug-resistant Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB [Phase 3]
Phase 3 trial evaluating a standard regimen of anti-tuberculosis drugs for patients with multidrug-resistant tuberculosis has completed with…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis [Phase 3]
Phase 3 trial evaluating various doses and durations of a regimen including linezolid with bedaquiline and pretomanid for drug-resistant tub…
-
FDA approval · 2022-12-21FDA Approved: PRETOMANID — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Pretomanid, submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China [Phase 4]
Phase 4 trial update assessing safety and effectiveness of a delamanid-containing regimen for multidrug-resistant tuberculosis in China.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of orally administered OPC-67683 for tuberculosis, including multidrug-resistant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis [Phase 2, Phase 3]
An open-label randomized trial evaluated a new treatment regimen for patients with multi-drug resistant tuberculosis, including phase 2 and …
-
FDA approval · 2021-09-23FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) from Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: PRACTECAL-PKPD Sub Study [Phase 2, Phase 3]
Phase 2/3 trial update for the PRACTECAL-PKPD Sub Study investigating treatment regimens for drug-resistant tuberculosis.
-
CLINICAL_TRIALS research · 2020-11-23Clinical Trial Update: A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) [Phase 2]
Phase 2 pediatric trial assessing safety, efficacy, and PK of delamanid in children with multidrug-resistant tuberculosis; completed with re…
-
FDA approval · 2020-05-27FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) submitted by Janssen Products, LP, updating the drug's approv…
-
FDA approval · 2020-01-06FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) submitted by Janssen Products, LP.
-
FDA approval · 2019-12-03FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved Janssen's supplemental application for SIRTURO (bedaquiline fumarate), signaling an updated labeling and/or expanded use fo…
-
FDA approval · 2019-08-15FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) submitted by Janssen Products, LP.
-
FDA approval · 2019-08-14FDA Approved: PRETOMANID — Original Application (Viatris Specialty LLC)
FDA approved pretomanid under NDA 212862 from Viatris Specialty LLC. The approval addresses treatment options for drug-resistant tuberculosi…
-
FDA approval · 2019-08-09FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
FDA approves Janssen's supplemental application for SIRTURO (bedaquiline fumarate).
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis [Phase 3]
Phase 3 trial update evaluating 6-month delamanid treatment for multidrug-resistant tuberculosis with posted results.
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB [NA]
This clinical trial update describes NGS-guided regimens of anti-tuberculosis drugs for multidrug-resistant tuberculosis, sponsored by Huash…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Tuberculosis in China
This entry notes the completion of a National Institute of Allergy and Infectious Diseases study conducted in China focused on tuberculosis.…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
The terminated trial assessed the MODS test for diagnosis of multidrug-resistant tuberculosis and for second-line antituberculous drug susce…
-
CLINICAL_TRIALS research · 2017-10-25Clinical Trial Update: Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru
This document reports an operational assessment of a Laboratory Information System for Multidrug-Resistant Tuberculosis in Lima, Peru. The s…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis
Completed clinical trial evaluating PCR on DNA extracted from slides and filter paper for detection of tuberculosis and multidrug-resistant …
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB [Phase 2, Phase 3]
A clinical trial update examining adjunctive recombinant human interleukin-2 therapy for multidrug-resistant tuberculosis across Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Line Probe Assay Evaluation Study
This clinical trial update reports completion of a study evaluating the performance of a line probe assay for detecting drug resistance in t…
-
FDA approval · 2016-02-10FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) from Janssen Products, LP.
-
FDA approval · 2015-12-09FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) from Janssen Products, LP.